Skip to main content
. 2019 Dec 18;19(2):1329–1335. doi: 10.3892/etm.2019.8345

Table V.

Correlation of lncRNA MALAT1 and lncRNA ANRIL with clinicopathological features.

Factors Relative expression of lncRNA MALAT1 t value P-value Relative expression of lncRNA ANRIL t value P-value
Sex 0.674 0.464 0.644
  Male (n=47) 0.62±0.10 0.422 0.63±0.09
  Female (n=39) 0.61±0.12 0.64±0.11
Age 0.886 0.879 0.382
  <57 years (n=41) 0.65±0.09 0.388 0.67±0.12
  ≥57 years (n=45) 0.63±0.12 0.65±0.09
BMI 1.316 0.192 0.422 0.675
  ≤23 (n=40) 0.67±0.10 0.65±0.12
  >23 (n=46) 0.64±0.11 0.66±0.10
Types 0.130 0.124
  Angle-closure (n=37) 0.63±0.09 1.530 0.61±0.10 1.555
  Open-angle (n=49) 0.66±0.09 0.65±0.13
Myopia 1.463 0.147 1.414 0.161
  Yes (n=52) 0.65±0.08 0.64±0.10
  No (n=34) 0.62±0.11 0.67±0.09
Stages <0.001
  I and II (n=47) 0.75±0.07 18.28 <0.001 0.74±0.08 17.63
  III and IV (n=39) 0.49±0.06 0.48±0.05

lncRNA, long non-coding RNA; BMI, body mass index.